Interaction ID
ncRI-40685453
Interaction Molecules
hsa-miR-106a-3p -- ATP8A1
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;motor cortex
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000124406
Description
Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. In vitro, its ATPase activity is selectively and stereospecifically stimulated by phosphatidylserine (PS). The flippase complex ATP8A1:TMEM30A seems to play a role in regulation of cell migration probably involving flippase-mediated translocation of phosphatidylethanolamine (PE) at the plasma membrane. Acts as aminophospholipid translocase at the plasma membrane in neuronal cells.
Pubmed ID | 24389009 | Journal | Neuron |
---|---|---|---|
Title | Transcriptome-wide discovery of microRNA binding sites in human brain. | ||
Author | Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, Ross CA, Xing Y, Davidson BL |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-106a-3p | acute myeloid leukemia | MNDR Database |
hsa-miR-106a-3p | acute T cell leukemia | MNDR Database |
hsa-miR-106a-3p | adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | adenoma | MNDR Database |
hsa-miR-106a-3p | Alzheimer's disease | MNDR Database |
hsa-miR-106a-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-106a-3p | aortic valve disease | MNDR Database |
hsa-miR-106a-3p | Arsenic Poisoning | MNDR Database |
hsa-miR-106a-3p | astrocytoma | MNDR Database |
hsa-miR-106a-3p | autism spectrum disorder | MNDR Database |
hsa-miR-106a-3p | autosomal recessive limb-girdle muscular dystrophy type 2A | MNDR Database |
hsa-miR-106a-3p | autosomal recessive limb-girdle muscular dystrophy type 2B | MNDR Database |
hsa-miR-106a-3p | B-cell lymphoma | MNDR Database |
hsa-miR-106a-3p | biliary tract cancer | MNDR Database |
hsa-miR-106a-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-106a-3p | bone disease | MNDR Database |
hsa-miR-106a-3p | brain disease | MNDR Database |
hsa-miR-106a-3p | breast cancer | MNDR Database |
hsa-miR-106a-3p | Breast Neoplasms | MNDR Database |
hsa-miR-106a-3p | Burkitt lymphoma | MNDR Database |
hsa-miR-106a-3p | cancer | MNDR Database |
hsa-miR-106a-3p | carcinoma | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-106a-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-106a-3p | cervical adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-106a-3p | chronic fatigue syndrome | MNDR Database |
hsa-miR-106a-3p | chronic lymphocytic leukemia | MNDR Database |
hsa-miR-106a-3p | chronic myeloid leukemia | MNDR Database |
hsa-miR-106a-3p | colon adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | colon cancer | MNDR Database |
hsa-miR-106a-3p | colorectal cancer | MNDR Database |
hsa-miR-106a-3p | Crohn's disease | MNDR Database |
hsa-miR-106a-3p | diabetes mellitus | MNDR Database |
hsa-miR-106a-3p | diffuse large B-cell lymphoma | MNDR Database |
hsa-miR-106a-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-106a-3p | Down syndrome | MNDR Database |
hsa-miR-106a-3p | Duke C | MNDR Database |
hsa-miR-106a-3p | embryonal cancer | MNDR Database |
hsa-miR-106a-3p | endometrial cancer | MNDR Database |
hsa-miR-106a-3p | Ependymoma | MNDR Database |
hsa-miR-106a-3p | esophageal cancer | MNDR Database |
hsa-miR-106a-3p | eye disease | MNDR Database |
hsa-miR-106a-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-106a-3p | Fatty Liver | MNDR Database |
hsa-miR-106a-3p | follicular lymphoma | MNDR Database |
hsa-miR-106a-3p | fragile X syndrome | MNDR Database |
hsa-miR-106a-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | gastric lymphoma | MNDR Database |
hsa-miR-106a-3p | Glioblastoma | MNDR Database |
hsa-miR-106a-3p | head and neck cancer | MNDR Database |
hsa-miR-106a-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Heart Failure | MNDR Database |
hsa-miR-106a-3p | hepatitis B | MNDR Database |
hsa-miR-106a-3p | Hepatitis, Viral, Human | MNDR Database |
hsa-miR-106a-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-106a-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-106a-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-106a-3p | Huntington's disease | MNDR Database |
hsa-miR-106a-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-106a-3p | Hypersomnolence, Idiopathic | MNDR Database |
hsa-miR-106a-3p | inflammatory bowel disease | MNDR Database |
hsa-miR-106a-3p | intellectual disability | MNDR Database |
hsa-miR-106a-3p | kidney cancer | MNDR Database |
hsa-miR-106a-3p | Lesch-Nyhan syndrome | MNDR Database |
hsa-miR-106a-3p | leukemia | MNDR Database |
hsa-miR-106a-3p | Lewy body dementia | MNDR Database |
hsa-miR-106a-3p | liposarcoma | MNDR Database |
hsa-miR-106a-3p | Liver Neoplasms | MNDR Database |
hsa-miR-106a-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | lung cancer | MNDR Database |
hsa-miR-106a-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-106a-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Lymphoblastoid | MNDR Database |
hsa-miR-106a-3p | lymphoma | MNDR Database |
hsa-miR-106a-3p | Lymphoma, Follicular | MNDR Database |
hsa-miR-106a-3p | Lymphoma, Non-Hodgkin | MNDR Database |
hsa-miR-106a-3p | malignant glioma | MNDR Database |
hsa-miR-106a-3p | medulloblastoma | MNDR Database |
hsa-miR-106a-3p | melanoma | MNDR Database |
hsa-miR-106a-3p | meningioma | MNDR Database |
hsa-miR-106a-3p | Mesothelioma | MNDR Database |
hsa-miR-106a-3p | multiple myeloma | MNDR Database |
hsa-miR-106a-3p | multiple sclerosis | MNDR Database |
hsa-miR-106a-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-106a-3p | muscular disease | MNDR Database |
hsa-miR-106a-3p | myelodysplastic/myeloproliferative neoplasm | MNDR Database |
hsa-miR-106a-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-106a-3p | nemaline myopathy | MNDR Database |
hsa-miR-106a-3p | Neoplasms | MNDR Database |
hsa-miR-106a-3p | nephroblastoma | MNDR Database |
hsa-miR-106a-3p | neuroblastoma | MNDR Database |
hsa-miR-106a-3p | neurodegenerative disease | MNDR Database |
hsa-miR-106a-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | osteosarcoma | MNDR Database |
hsa-miR-106a-3p | ovarian carcinoma | MNDR Database |
hsa-miR-106a-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-106a-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | pancreatic cancer | MNDR Database |
hsa-miR-106a-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-106a-3p | papillary thyroid carcinoma | MNDR Database |
hsa-miR-106a-3p | Parkinson's disease | MNDR Database |
hsa-miR-106a-3p | Precursor Cell Lymphoblastic Leukemia-Lymphoma | MNDR Database |
hsa-miR-106a-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-106a-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-106a-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-106a-3p | Pseudorabies | MNDR Database |
hsa-miR-106a-3p | psoriasis | MNDR Database |
hsa-miR-106a-3p | rectum adenocarcinoma | MNDR Database |
hsa-miR-106a-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-106a-3p | renal cell carcinoma | MNDR Database |
hsa-miR-106a-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-106a-3p | Retinal Neovascularization | MNDR Database |
hsa-miR-106a-3p | rhabdomyosarcoma | MNDR Database |
hsa-miR-106a-3p | Sepsis | MNDR Database |
hsa-miR-106a-3p | small intestine cancer | MNDR Database |
hsa-miR-106a-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-106a-3p | stomach cancer | MNDR Database |
hsa-miR-106a-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-106a-3p | syndrome | MNDR Database |
hsa-miR-106a-3p | T-cell leukemia | MNDR Database |
hsa-miR-106a-3p | temporal lobe epilepsy | MNDR Database |
hsa-miR-106a-3p | testicular germ cell cancer | MNDR Database |
hsa-miR-106a-3p | thyroid cancer | MNDR Database |
hsa-miR-106a-3p | thyroid carcinoma | MNDR Database |
hsa-miR-106a-3p | Toxoplasma | MNDR Database |
hsa-miR-106a-3p | toxoplasmosis | MNDR Database |
hsa-miR-106a-3p | Urinary Bladder Neoplasms | MNDR Database |
hsa-miR-106a-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-106a-3p | Uterine Cervical Neoplasms | MNDR Database |
hsa-miR-106a-3p | vascular disease | MNDR Database |